Duke Cancer Institute | |
---|---|
Geography | |
Location | Durham, North Carolina, United States |
Coordinates | 36°00′14″N78°56′20″W / 36.003767°N 78.938812°W |
Organization | |
Type | Specialist |
Affiliated university | Duke University |
Services | |
Speciality | Oncology |
History | |
Opened | 1971 |
Links | |
Website | dukecancerinstitute |
Lists | Hospitals in North Carolina |
The Duke Cancer Institute (DCI) is a National Cancer Institute-designated Comprehensive Cancer Center, research facility, and hospital. [1] Founded in 1971, the center is part of the Duke University School of Medicine and Duke University Health System located in Durham, North Carolina, United States. [2] [3]
The center specializes in the treatment and prevention of cancer and was ranked 41st in the U.S. News & World Report's 2021 list of top cancer hospitals. [4] More than 10,000 new cancer patients are seen at Duke each year. [5] The institute signed the National Cancer Act of 1971 and became an NCI-designated cancer center in 1973. [6]
In November 2010, Victor Dzau, MD, chancellor of health affairs for Duke University, formally unveiled the Duke Cancer Institute, during the topping out ceremony for the new building. [7]
The DCI is a single entity—the first of its kind at Duke—that integrates and aligns patient care and basic and clinical research with the goals of improving patient outcomes, decreasing the burden of cancer and accelerating scientific progress. [8]
Michael B. Kastan, a cancer scientist and Director of the Comprehensive Cancer Center at St. Jude Children’s Research Hospital, was named as the first Executive Director of the Duke Cancer Institute in May 2011. [9] Eun-Sil Shelley Hwang became the institute's first female Chief of Breast Surgery. [10]
On February 27, 2012, the Duke Cancer Institute opened the Duke Cancer Center, a new seven-floor building devoted exclusively to cancer care. [11]
In June 2018, the institute published a study in The New England Journal of Medicine showing how a genetically modified poliovirus therapy improved long-term survival for patients with recurrent glioblastoma. [12] [13] [14] Patients showed a three-year survival rate of 21 percent. [15]
The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the world and one of the original three NCI-designated comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located within the Texas Medical Center, the largest medical center and life sciences destination in the world. MD Anderson Cancer Center has consistently ranked #1 among the best hospitals for cancer care and research in the U.S. and worldwide, and it has held the #1 position 20 times in the last 23 years in U.S. News & World Report's Best Hospitals rankings for cancer care. As of 2023, MD Anderson Cancer Center is home to the highest number of cancer clinical trials in the world and has received more NCI-funded projects than any other U.S. institute. For 2024, Newsweek placed MD Anderson at #1 in their annual list of the World's Best Specialized Hospitals in oncology.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye (intravitreal).
Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus. Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida. In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.
The Duke University School of Medicine, commonly known as Duke Med, is the medical school of Duke University. It was established in 1925 by James B. Duke.
Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, is a pre-cancerous or non-invasive cancerous lesion of the breast. DCIS is classified as Stage 0. It rarely produces symptoms or a breast lump that can be felt, typically being detected through screening mammography. It has been diagnosed in a significant percentage of men.
Duke University Hospital is a 1062 -bed acute care facility and an academic tertiary care facility located in Durham, North Carolina, United States. Established in 1930, it is the flagship teaching hospital for the Duke University Health System, a network of physicians and hospitals serving Durham County and Wake County, North Carolina, and surrounding areas, as well as one of three Level I referral centers for the Research Triangle of North Carolina. It is affiliated with the Duke University School of Medicine.
NYU Langone Health is an academic medical center located in New York City, New York, United States. The health system consists of the NYU Grossman School of Medicine and NYU Grossman Long Island School of Medicine, both part of New York University (NYU), and more than 300 locations throughout the New York City Region and Florida, including six inpatient facilities: Tisch Hospital; Kimmel Pavilion; NYU Langone Orthopedic Hospital; Hassenfeld Children's Hospital; NYU Langone Hospital–Brooklyn; and NYU Langone Hospital–Long Island. It is also home to Rusk Rehabilitation. NYU Langone Health is one of the largest healthcare systems in the Northeast, with more than 49,000 employees.
The University of Florida College of Medicine – Jacksonville is the largest of the three University of Florida Health Science Center Jacksonville colleges — medicine, nursing and pharmacy. The college's 16 clinical science departments house more than 440 faculty members and 380 residents and fellows. The college offers 34 accredited graduate medical education programs and 10 non-standard programs.
Alternating electric field therapy, sometimes called tumor treating fields (TTFields), is a type of electromagnetic field therapy using low-intensity, intermediate frequency electrical fields to treat cancer. TTFields disrupt cell division by disrupting dipole alignment and inducing dielectrophoresis of critical molecules and organelles during mitosis. These anti-mitotic effects lead to cell death, slowing cancer growth. A TTField-treatment device manufactured by the Israeli company Novocure is approved in the United States and Europe for the treatment of newly diagnosed and recurrent glioblastoma, malignant pleural mesothelioma (MPM), and is undergoing clinical trials for several other tumor types. Despite earning regulatory approval, the efficacy of this technology remains controversial among medical experts.
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 32 cancer centers dedicated to improving the quality and effectiveness of cancer care.
Good Samaritan University Hospital is a 537-bed non-profit teaching hospital on Long Island located in West Islip, New York. The hospital contains 100 nursing home beds as well as operates an adult Level I trauma center and a pediatric Level II trauma center. Good Samaritan University Hospital opened in May 1959, and has expanded several times since opening. It has been Magnet-designed for its quality nursing since 2006, and is a member of Catholic Health. The hospital is also a major regional clinical campus for clinical clerkships and postgraduate medical training affiliated with the New York Institute of Technology College of Osteopathic Medicine, one of the largest medical schools in the United States.
Gibbs Cancer Center & Research Institute is a cancer treatment and research facility in Upstate South Carolina. Gibbs Cancer Center is associated with the NCI Community Cancer Centers Program and the Medical University of South Carolina. Gibbs has several locations across the upstate of South Carolina, including Comprehensive Cancer Centers at both Spartanburg Medical Center and Pelham Medical Center. Additional infusion facilities are located in Gaffney, Union, Mary Black and North Grove.
Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital Yale New Haven Health System, effective February 1, 2022. He also is Deputy Dean for Cancer Research at Yale School of Medicine. From 1997 to 2021, he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston, Massachusetts. Beginning in 2013, he held a range of institutional roles at Dana-Farber, including Chief of Clinical Development, the Thompson Chair in Breast Cancer Research and Director of the Dana-Farber/Harvard SPORE in Breast Cancer. He also served as a Professor of Medicine at Harvard Medical School. He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023. His career has been focused on breast cancer treatment and research.
Sonidegib (INN), sold under the brand name Odomzo, is a medication used to treat cancer.
Dr. Matthias Gromeier is a Professor in the Department of Neurosurgery at Duke University Medical Center, who has developed a way to re-engineer a poliovirus to inspire the human immune system to kill cancer cells in a specific set of cancers. The re-engineered virus, called PVSRIPO, cannot replicate itself in normal cells, but can replicate itself in cancer cells that have an overabundance of the protein marker that the poliovirus targets.
John Howard Sampson is an American neurosurgeon and University of Colorado School of Medicine Dean and Vice Chancellor for Health Affairs for CU Anschutz who was formerly chief of the department of neurosurgery at Duke University where he serves as a professor of surgery, biomedical engineering, immunology, and pathology.
Winship Cancer Institute of Emory University is a nonprofit cancer research and patient care center based in Atlanta, Georgia. Winship Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center in Georgia.
Carolyn Kaelin was an American cancer surgeon. She worked at the Dana–Farber Cancer Institute and founded the Comprehensive Breast Health Center at Brigham and Women’s Hospital in 1995.
University of Virginia Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center affiliated with the University of Virginia School of Medicine and the UVA Health System.